Key result
Transapical thoracic endovascular aortic repair achieved 100% procedural success with no 30-day mortality in 8 patients unsuitable for transfemoral access.
Why the study?
Does the transapical approach for TEVAR provide a feasible and safe alternative in patients with thoracic aortic pathology unsuitable for transfemoral access?
Population
n=8 patients with thoracic aortic pathology denied standard TEVAR due to extensive calcification and…
Design
Case_series
Follow-up
1 year
Authors
Loading...
May enable TEVAR in prohibitive femoral anatomy; leaves open safety, durability, and outcome questions for prospective evaluation.
Observational (n=8)
No
Does the transapical approach for TEVAR provide a feasible and safe alternative in patients with thoracic aortic pathology unsuitable for transfemoral access?
Transapical TEVAR is a feasible alternative for patients with thoracic aortic pathology who have distal vessels unsuitable for transfemoral access.
Ghazy et al. (2016) conducted an observational in Thoracic aortic pathology (n=8). Transapical thoracic endovascular aortic repair (TaTEVAR) was evaluated on Procedural success. Transapical thoracic endovascular aortic repair achieved 100% procedural success with no 30-day mortality in 8 patients unsuitable for transfemoral access.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: